Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-13

Clinical Trial Update: MAST - Magnesium for Sickle Cell Acute Crisis in Children [Phase 3]

View source ↗

Summary

Phase 3 trial assessing magnesium sulfate for acute sickle cell crisis in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Anemia, Sickle Cell | Phase 3 | Status: COMPLETED